Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 70Carcinoma, Hepatocellular 4Carcinoma, Renal Cell 3Prostate Adenocarcinoma 2Ovarian Neoplasms 2Neoplasms 2Carcinoma, Adenoid Cystic 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage II Prostate Adenocarcinoma 1Prostatic Diseases 1Prostate-specific Membrane Antigen 1Prostate Cancer Metastatic 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Lobular 1Breast Neoplasms 1Biochemically Recurrent Prostate Carcinoma 1Adenocarcinoma 1

Interventions

Radiotherapy 4Carboplatin 4Trastuzumab 3Fulvestrant 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Paclitaxel 2Magnetic Resonance Spectroscopy 2Letrozole 2Docetaxel 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1gallium 68 PSMA-11 1fluciclovine F-18 1entrectinib 1Zolpidem 1Vorinostat 1Vinorelbine 1Venlafaxine Hydrochloride 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Lobular × gallium 68 PSMA-11 × Clear all
NCT04750473 2025-01-17

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Emory University

Phase 1 Completed
20 enrolled 7 charts

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡